[Minimal change nephrotic syndrome: Pathogenesis, pathophysiology and therapy].
Wakui
Hideki
H
Third Department of Internal Medicine, Akita University School of Medicine.
Komatsuda
Atsushi
A
D000418:Albumins / Q000627:therapeutic use; D000818:Animals; D004039:Diet, Sodium-Restricted; D005919:Glomerular Filtration Rate; D006466:Hemopexin / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008565:Membrane Proteins / Q000502:physiology; D009402:Nephrosis, Lipoid / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D011507:Proteinuria / Q000209:etiology; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000627:therapeutic use; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology
D000418:Albumins; D007166:Immunosuppressive Agents; D008565:Membrane Proteins; D049994:Sodium Potassium Chloride Symporter Inhibitors; C113267:nephrin; D006466:Hemopexin